Application of artemisinin compound in preparation of medicine for resisting renal vascular smooth muscle lipoma related to nodular sclerosis

• Main Authors: YANG HONGJUN, CHEN PENG, GUO GANG, DENG SHIWEN, LIU LANYIBO, CHANG XIAO, CAO JUNXIAN
• Format: Patent
• Language: Chinese; English
• Published: 03.06.2025
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The invention belongs to the technical field of biological medicines, and particularly relates to application of artemisinin compounds in preparation of medicines for resisting renal vascular smooth muscle lipoma related to nodular sclerosis. The artemisinin compound can inhibit the growth of renal vascular smooth muscle lipoma cells related to nodular sclerosis, has the efficacy of treating renal vascular smooth muscle lipoma related to nodular sclerosis, and meanwhile, the artemisinin compound is relatively rich in source, relatively low in cost and suitable for industrial production. The artemisinin compound can be used for preparing the medicine for treating the renal vascular smooth muscle lipoma related to the nodular sclerosis, and a new potential medicine is provided for treating the renal vascular smooth muscle lipoma related to the nodular sclerosis. 本发明属于生物医药技术领域，具体涉及青蒿素类化合物在制备抗结节性硬化症相关肾血管平滑肌脂肪瘤药物中的应用。所述青蒿素类化合物能够抑制结节性硬化症相关肾血管平滑肌脂肪瘤细胞的生长，具有治疗结节性硬化症相关肾血管平滑肌脂肪瘤的药效，同时，青蒿素类化合物来源相对丰富，成本较低，青蒿素类化合物可用于制备治疗结